Overview
This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.
Eligibility
Inclusion Criteria:
- Any patient who has been treated using Calcium Electroporation
- Any patient who has been treated using Electrochemotherapy
- Patients must be mentally capable of understanding the information given
- Patients must give written informed consent.
Exclusion Criteria:
- None